Breaking News Just Announced
This tiny telehealth stock is up over 50% in the past month.
Put it on your watchlist now

CMPX Insider Trading (Compass Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $18,750,000.50
Insider Selling (Last 12 Months): $0.00

Compass Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Compass Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Compass Therapeutics Share Price & Price History

Current Price: $3.22
Price Change: Price Increase of +0.02 (0.63%)
As of 11/26/2021 08:53 PM ET

This chart shows the closing price history over time for CMPX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
How This Rare Metal Is Going To Solve A $173 TRILLION World Problem… And Could Benefit Investors
According to Bloomberg NEF, changing the world to "All Green Energy" could cost about $173 trillion. And without this rare metal, going green would be IMPOSSIBLE. That's why there's a literal "gold rush" to find it. (HINT: It's not electric vehicles, nuclear power, or wind energy).
Show Me How This Industry Could Explode!

Compass Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/4/2021Carl L GordonDirectorBuy5,357,143$3.50$18,750,000.50View SEC Filing Icon  
See Full Table
Insider Trading at Compass Therapeutics?
Sign-up to receive's daily insider buying and selling report for Compass Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Compass Therapeutics (OTC:CMPX)

Compass Therapeutics logo
Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. The company's lead product candidate includes CTX-471. Compass Therapeutics Inc. is based in Boston, MA.
Read More on Compass Therapeutics

Today's Range

Now: $3.22
Low: $2.84
High: $3.23

50 Day Range

MA: $3.44
Low: $2.90
High: $3.98

52 Week Range

Now: $3.22
Low: $2.01
High: $11.00


533,900 shs

Average Volume

50,614 shs

Market Capitalization

$315.66 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Compass Therapeutics?

Compass Therapeutics' top insider investors include:
  1. Carl L Gordon (Director)
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush."
Experts predict that the global lithium market will balloon by 500%. That's wonderful news for investors, because a "sure-thing" like this appears once in a lifetime. And this small-cap company just snagged what could be one of the world's largest lithium deposits.
Discover This Company's MASSIVE Lithium Opportunit